retatrutide dosage clinical trials retatrutide Dosing: Early Trial Insights on How It Might Work When will Retatrutide be available

Whats the difference between GLP-1s

This is the most accessible option for most patients

their use for weight management outside this indication is not routinely commissioned on the NHS

Some well-known options include: Ozempic Wegovy Mounjaro Rybelsus What Are These Treatments Used For

Cardiovascular protection Ozempic has proven cardiovascular benefits supported by two major trials

The first head-to-head clinical trial (SURMOUNT-5, published in the New England Journal of Medicine in 2025) showed tirzepatide produced 20.2% average weight loss at 72 weeks compared to 13.7% for semaglutide approximately 47% greater relative weight loss